Fingerprint
Dive into the research topics of 'A phase 1, open-label, dose escalation study of intravenous paricalcitol in combination with gemcitabine in patients with advanced malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically